Manufacturer record
Ciphem Pharma: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Ciphem Pharma (Gujarat) were declared Not of Standard Quality between May 2025 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
3 records linked to Ciphem Pharma in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Cefixime with Lactic Acid Bacillus Dispersible Tablets | CT/25/792Mfg 2026-01 · Exp 2027-12 | The sample does not conform to the claim with respect to Assay of Cefixime Trihydrate Eq. to Anhydrous Cefixime.Assay | DTL JaipurState lab | Jul 2026 |
| Cefixime & Ofloxacin Tablets | CT/25/277Mfg 2025-07 · Exp 2027-06 | Assay of Cefixime Anhydrous and OfloxacinAssay | DTL, ThrissurState lab | Mar 2026 |
| Amoxycillin with Potassium Clavulanate Tablets I.P. (CLAIM ? CV 625) | CT/24/747Mfg 2024-10 · Exp 2026-03 | The Sample does not conform to standard in respect of the test for Uniformity of weight, Dissolution & AssayAssay | State Drugs Testing Laboratory, Agartala, TripuraState lab | May 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.